Dose-escalation study to evaluate safety and efficacy of QM1114-DP

• Research type

  Research Study

• Full title

  A randomised, double-blind, placebo-controlled, single treatment, dose-escalation study to evaluate the safety and efficacy of QM1114-DP in healthy male and female subjects with moderate to severe upper facial wrinkles

• IRAS ID

  129177

• Contact name

  Ulrike Lorch

• Contact email

  u.lorch@richmondpharmacology.com

• Sponsor organisation

  Galderma Aesthetic & Corrective GBU

• Eudract number

  2013-001035-43

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  13/SC/0158

• Date of REC Opinion

  15 May 2013

• REC opinion

  Further Information Favourable Opinion